Institutional Ownership Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE). We have compiled data on the 287 institutions that hold shares in the stock, with a total of 88.1 Million shares, which have been reported (via 13F filing form) to have a value of $4.86 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Avoro Capital Advisors LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
830,000
shares
|
$45.2 Million
0.47% of portfolio
|
Q1 2024
Added 137.14%
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
716,947
shares
|
$39 Million
0.2% of portfolio
|
Q2 2024
Added 62.65%
|
|
Candriam S.C.A.
|
Aug 05, 2024 Q2 2024 |
688,942
shares
|
$37.5 Million
0.17% of portfolio
|
Q2 2024
Added 33.1%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Aug 14, 2024 Q2 2024 |
634,327
shares
|
$34.5 Million
0.11% of portfolio
|
Q2 2024
Reduced 7.75%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 13, 2024 Q2 2024 |
629,514
shares
|
$34.3 Million
0.0% of portfolio
|
Q2 2024
Added 72.89%
|
|
Man Group PLC
London, X0 |
Aug 14, 2024 Q2 2024 |
628,726
shares
|
$34.2 Million
0.07% of portfolio
|
Q2 2024
Added 309.22%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
582,976
shares
|
$31.7 Million
0.03% of portfolio
|
Q2 2023
Added 74.53%
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2024 Q2 2024 |
568,309
shares
|
$30.9 Million
0.06% of portfolio
|
Q2 2024
Added 36.84%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Aug 13, 2024 Q2 2024 |
556,818
shares
|
$30.3 Million
0.03% of portfolio
|
Q2 2024
Reduced 46.27%
|
|
Fred Alger Management, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
548,905
shares
|
$29.9 Million
0.11% of portfolio
|
Q2 2024
Reduced 5.61%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2024 Q2 2024 |
547,818
shares
|
$29.8 Million
0.0% of portfolio
|
Q2 2024
Added 27.24%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Sep 16, 2024 Q2 2024 |
539,749
shares
|
$29.4 Million
0.06% of portfolio
|
Q2 2024
Added 786.29%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2024 Q2 2024 |
537,616
shares
|
$29.3 Million
0.0% of portfolio
|
Q2 2024
Added 10.99%
|
|
Driehaus Capital Management LLC
Chicago, IL |
Aug 15, 2024 Q2 2024 |
528,180
shares
|
$28.7 Million
0.23% of portfolio
|
Q2 2024
Added 35.68%
|
|
Eagle Health Investments LP
Greenwich, CT |
Aug 13, 2024 Q2 2024 |
524,500
shares
|
$28.5 Million
3.79% of portfolio
|
Q2 2024
Added 75.01%
|
|
Morgan Stanley
New York, NY |
Aug 14, 2024 Q2 2024 |
497,969
shares
|
$27.1 Million
0.0% of portfolio
|
Q1 2024
Reduced 15.59%
|
|
Emerald Advisers, LLC
|
Aug 06, 2024 Q2 2024 |
486,682
shares
|
$26.5 Million
0.9% of portfolio
|
Q2 2024
Reduced 0.3%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2024 Q2 2024 |
442,200
shares
|
$24.1 Million
0.04% of portfolio
|
Q2 2024
Reduced 1.34%
|
|
Axa S.A.
Paris, I0 |
Aug 14, 2024 Q2 2024 |
425,334
shares
|
$23.2 Million
0.05% of portfolio
|
Q2 2024
Added 27.82%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 15, 2024 Q2 2024 |
425,000
shares
|
$23.1 Million
1.03% of portfolio
|
Q2 2024
New holding
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Aug 14, 2024 Q2 2024 |
415,000
shares
|
$22.6 Million
0.09% of portfolio
|
Q2 2024
Added 36.02%
|
|
Gw&K Investment Management, LLC
Boston, MA |
Aug 12, 2024 Q2 2024 |
406,519
shares
|
$22.1 Million
0.15% of portfolio
|
Q2 2024
Added 34.0%
|
|
Walleye Capital LLC
Plymouth, MN |
Aug 14, 2024 Q2 2024 |
390,592
shares
|
$21.3 Million
0.03% of portfolio
|
Q2 2024
Added 46.49%
|
|
Emerald Mutual Fund Advisers Trust
|
Aug 06, 2024 Q2 2024 |
390,524
shares
|
$21.3 Million
0.91% of portfolio
|
Q2 2024
Added 1.35%
|
|
Northern Trust Corp
Chicago, IL |
Aug 14, 2024 Q2 2024 |
381,881
shares
|
$20.8 Million
0.0% of portfolio
|
Q2 2024
Added 3.88%
|